No Excuses: US FDA Wants Early, Thorough Dosage Optimization For Cancer Drugs

 
• By Sue Sutter
  
Camera lens
US FDA wants sponsors to focus more attention on dosage optimization before submitting a marketing application. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from Pathways & Standards